Licensing Deal Finalized for Cancer-Targeting Antibodies

A Inpart Case Study

Preview of the The University of Tennessee Case Study

Case study about The University of Tennessee working with Inpart.

View this case study…

The University of Tennessee

Stefan Schweizer

Licensing Associate

Inpart

44 Case Studies